---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-009996"
form_type: "8-K"
ticker: "AZTR"
cik: "0001701478"
company_name: "Azitra, Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T16:33:45.125386+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Azitra Q1 net loss $3.1M, cash $3.2M; secures up to $20M funding from Alumni Capital

## Summary
- Net loss $3.1M for Q1 2025 vs $2.9M in Q1 2024; R&D $1.3M, G&A $1.9M.
- Cash $3.2M as of March 31, 2025; signed up to $20M purchase agreement with Alumni Capital LP.
- Closed two public offerings raising $2.2M.
- ATR-12 Phase 1b initial safety data expected 1H 2025; topline data by YE 2025.
- ATR-04 Phase 1/2 first patient dosing expected 1H 2025; ASCO poster accepted.

## SEC filing metadata
- accession: 0001641172-25-009996
- form_type: 8-K
- ticker: AZTR
- cik: 0001701478
- company_name: Azitra, Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701478/000164117225009996/0001641172-25-009996-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701478/000164117225009996/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-009996
- JSON: https://secwatch.observer/filing/0001641172-25-009996.json
- Plain text: https://secwatch.observer/filing/0001641172-25-009996.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.